Jump to content

Apolipoproteins as therapeutic agents

Featured Replies

Hello, I was reading a scientific article which reported that oral administration of a mutated form of apolipoprotein A1 (ApoA-I) to mice fed with a high cholesterol diet significantly lowers the rate of formation of atherosclerotic plaques. But I can't understand how this is possible. I mean, if mice are given the protein by mouth, it is digested into single amino acids, isn't it? So, how can it reduce plaque formation in the circulatory system if it is broken down by the digestive system?

Thanks in advance!

Edited by pegasus10

The degradation is often incomplete and if fed sufficient amounts they can exert various actions. Note that for some of these actions the molecule may not have to be fully intact, either.

Archived

This topic is now archived and is closed to further replies.

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.

Configure browser push notifications

Chrome (Android)
  1. Tap the lock icon next to the address bar.
  2. Tap Permissions → Notifications.
  3. Adjust your preference.
Chrome (Desktop)
  1. Click the padlock icon in the address bar.
  2. Select Site settings.
  3. Find Notifications and adjust your preference.